There is pressure to introduce innovations earlier, for example, through Early Access to Medicine Schemes. This increases uncertainty because there are often lower levels of evidence than with more mature technologies. Decision makers apply scientific and societal values when considering new health technologies, but innovations with a high level of uncertainty may challenge these. Aimed at HTA specialists and those interested in decisions on innovative treatments, the panel will allow debate about ethics.
|Title of host publication||HTAi 2015 – 12th Annual Meeting|
|Number of pages||1|
|Publication status||Published - 2015|
|Event||Global Efforts in Knowledge Transfer: HTA to Health Policy. HTAi 2015 – 12th Annual Meeting - Oslo|
Duration: 15 Jun 2015 → 17 Jun 2015
|Conference||Global Efforts in Knowledge Transfer: HTA to Health Policy. HTAi 2015 – 12th Annual Meeting|
|Period||15/6/15 → 17/6/15|